Reuters logo
BRIEF-Mayne Pharma posts FY profit attributable of $88.6 mln
August 25, 2017 / 12:15 AM / a month ago

BRIEF-Mayne Pharma posts FY profit attributable of $88.6 mln

Aug 25 (Reuters) - Mayne Pharma Group Ltd:

* FY revenue from ordinary activities up 114% to $572.6 million

* FY profit attributable to equity holders of parent $88.6 million versus $37.4 million Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below